HR 2423
114th Congress
House
To amend the Federal Food, Drug, and Cosmetic Act with respect to valid scientific evidence.
Health
Drug safety, medical device, and laboratory regulationHealth technology, devices, suppliesScientific communication
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 22, 2015
Referred to the Subcommittee on Health.
May 19, 2015
Referred to the House Committee on Energy and Commerce.
May 19, 2015
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health.
Plain-English summary
This bill amends the Federal Food, Drug, and Cosmetic Act to define “valid scientific evidence” to include well-documented case histories or studies published in peer-reviewed journals for purposes of the Food and Drug Administration (FDA) determining the effectiveness of a medical device without clinical investigation. Under specified conditions, the FDA may request the data underlying a study that is offered as valid scientific evidence.
Related & companion bills
1
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cite this page
U.S. Congress. (2026). H.R. 2423: To amend the Federal Food, Drug, and Cosmetic Act with respect to valid scientific evidence.. 114th Congress. Open America. https://openamerica.io/bill/114-HR-2423/
"H.R. 2423: To amend the Federal Food, Drug, and Cosmetic Act with respect to valid scientific evidence.." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-2423/.
H.R. 2423, 114th Cong. (2026), https://openamerica.io/bill/114-HR-2423/.
[H.R. 2423: To amend the Federal Food, Drug, and Cosmetic Act with respect to valid scientific evidence.](https://openamerica.io/bill/114-HR-2423/)